Allen, Mitchell E.
Pennington, Edward Ross
Perry, Justin B.
Dadoo, Sahil
Makrecka-Kuka, Marina http://orcid.org/0000-0003-4549-1993
Dambrova, Maija http://orcid.org/0000-0002-1739-0928
Moukdar, Fatiha
Patel, Hetal D.
Han, Xianlin http://orcid.org/0000-0002-8615-2413
Kidd, Grahame K.
Benson, Emily K.
Raisch, Tristan B.
Poelzing, Steven http://orcid.org/0000-0002-6979-1264
Brown, David A.
Shaikh, Saame Raza http://orcid.org/0000-0003-1950-2521
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (1R01HL12364)
UNC | Nutrition Obesity Research Center, University of North Carolina (P30DK056350)
Stealth BioTherapeutics
Article History
Received: 23 May 2019
Accepted: 23 June 2020
First Online: 17 July 2020
Competing interests
: D.A.B. and S.R.S. have served as consultants for Stealth BioTherapeutics, which is developing elamipretide for clinical indications. After submission of this manuscript draft for review, D.A.B. transitioned from academia to full-time employment with Stealth BioTherapeutics. Accordingly, D.A.B. receives compensation and equity/shares commensurate with this employment. All other authors have no competing interests to disclose.